UNITED THERAPEUTICS (UTH MU) stock market data APIs
€417.6082
0(0%)
as of December 5, 2025
Try our APIs with
free plan!
UNITED THERAPEUTICS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for UTH.MU.
Prev. Close
417.6082
Open
417.6082
High
417.6082
Low
417.6082
52 wk Range
240.7-421.6
Market Cap
7 520 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get UNITED THERAPEUTICS data using free add-ons & libraries
Get UNITED THERAPEUTICS Fundamental Data
UNITED THERAPEUTICS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
UNITED THERAPEUTICS News
New
Flurry of Bullish Inflows Sends United Therapeutics Higher
UTHR is a biotechnology company that develops and sells treatments for chronic and life-threatening conditions, with products including Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company...
A Fresh Look at United Therapeutics (UTHR) Valuation After Strong Share Price Gains
United Therapeutics (UTHR) has seen its stock steadily climb over the past month, delivering a 13% gain and drawing attention from investors. This momentum comes as the company continues to post doubl...
United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare Base
After consolidating for several months at the end of 2024, United Therapeutics stock made a comeback in early September this year. United Therapeutics stock is now trading above all its key moving ave...
2 Mooning Stocks on Our Buy List and 1 That Underwhelm
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial p...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
